Work

OP025 Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice

Year: 2017

Type: article

Study design: Observational Study

Source: Journal of Crohn s and Colitis

DOI: 10.1093/ecco-jcc/jjx002.024

Authors: S. Steiner, E. King, K. Park, D. Pashankar, H. Shashidhar, B. Sudel, S. Eichner, S. Chen, J. Pratt, R. Colletti, ImproveCareNow Network, Burlington, United States

Institutions: Riley Hospital for Children, Indiana University School of Medicine, Cincinnati Children's Hospital Medical Center, Lucile Packard Children's Hospital, Stanford University, University of Minnesota, AbbVie (United States), University of Vermont, University of Vermont Children’s Hospital

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2587256993

FWCI:

Cites:

Cited by:

Related to: 10